Access Vascular and Medline Enter Multi-Year Agreement to Launch Cobranded Next-Generation Vascular Access Catheters
Hospitals across the United States gain access to clinically differentiated midline and PICC catheters designed to combat thrombosis and infection
BILLERICA, Mass.–(BUSINESS WIRE)–Access Vascular, Inc. (“AVI”), a medical device company specializing in developing advanced vascular access solutions, and Medline, the largest provider of medical-surgical products and supply chain solutions serving all points of care, today announced a multi-year agreement to accelerate the rollout of AVI’s next-generation catheters, HydroMID® and HydroPICC®, which recently received an anti-thrombogenic indication from the FDA. The initiative bolsters Medline’s existing deep portfolio in vascular access, while leveraging its substantial acute care market presence and clinical expertise in infection prevention and ability to deliver industry leading customized kitting solutions.
